Goodwin advised Quentis Therapeutics in the deal Quentis Therapeutics Inc., completed a $48 million Series A financing co-led by founding investor Versant Ventures and by Polaris…
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here
